POINT BIOPHARMA GLOBAL INC (PNT) Forecast, Price Target & Analyst Ratings

NASDAQ:PNT • US7305411099

Current stock price

12.5 USD
+0.02 (+0.16%)
At close:
12.51 USD
+0.01 (+0.08%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for POINT BIOPHARMA GLOBAL INC (PNT).

Forecast Snapshot

Consensus Price Target

Price Target
$15.05
+ 20.36% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 22, 2024
Period
Q4 / 2023
EPS Estimate
-$0.26
Revenue Estimate
2.289M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
69.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$15.05
Upside
+ 20.36%
From current price of $12.50 to mean target of $15.05, Based on 15 analyst forecasts
Low
$12.63
Median
$12.75
High
$28.35

Price Target Revisions

1 Month
0.00%
3 Months
2.12%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for PNT. The average price target is 15.05 USD. This implies a price increase of 20.36% is expected in the next year compared to the current price of 12.5.
The average price target has been revised upward by 2.12% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PNT Current Analyst RatingPNT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

PNT Historical Analyst RatingsPNT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
69.33%
PNT was analyzed by 15 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about PNT.
In the previous month the buy percentage consensus was at a similar level.
PNT was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-12-21Brookline CapitalDowngrade Buy -> Hold
2023-10-24Piper SandlerDowngrade Overweight -> Neutral
2023-10-06Raymond JamesDowngrade Outperform -> Market Perform
2023-10-04JonesTradingDowngrade Buy -> Hold
2023-10-04Truist SecuritiesDowngrade Buy -> Hold
2023-05-16OppenheimerReiterate Outperform -> Outperform
2022-12-14Raymond JamesInitiate Outperform
2022-11-30SVB LeerinkInitiate Outperform
2022-11-15Truist SecuritiesMaintains Buy
2022-10-11OppenheimerInitiate Outperform
2022-09-16Truist SecuritiesInitiate Buy
2022-09-14BerenbergInitiate Buy
2022-09-07JonesTradingInitiate Buy
2022-08-16GuggenheimInitiate Buy
2022-07-06William BlairInitiate Outperform
2022-05-26JefferiesUpgrade Hold -> Buy
2021-12-17MizuhoInitiate Underperform
2021-07-29Cowen & Co.Initiate Outperform
2021-07-27JefferiesInitiate Hold
2021-07-26Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 22, 2024
Period
Q4 / 2023
EPS Estimate
-$0.26
Revenue Estimate
2.289M
Revenue Q2Q
-98.99%
EPS Q2Q
1.39%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
83.86%
EPS (1 Month)
0.00%
EPS (3 Months)
14.94%

Next Earnings Summary

PNT is expected to report earnings on 3/22/2024. The consensus EPS estimate for the next earnings is -0.26 USD and the consensus revenue estimate is 2.29M USD.
The next earnings revenue estimate has been revised upward by 83.86% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
PNT revenue by date.PNT revenue by date.
226.6M20.448M
-90.98%		35.182M
72.06%		228.64M
549.88%		146.86M
-35.77%		365.44M
148.84%		649.09M
77.62%		476.94M
-26.52%		569.65M
19.44%
EBITDA
YoY % growth
PNT ebitda by date.PNT ebitda by date.
N/AN/A126.9M-125.24M
-198.69%		-142.41M
-13.71%		63.63M
144.68%		-138.37M
-317.46%		N/AN/AN/AN/A
EBIT
YoY % growth
PNT ebit by date.PNT ebit by date.
-13.1M-45.5M
-247.33%		125.5M
375.82%		-120.451M
-195.98%		-108.241M
10.14%		-15.595M
85.59%		-85.727M
-449.70%		54.341M
163.39%		205.09M
277.41%		145.62M
-29.00%		217.78M
49.55%
Operating Margin
PNT operating margin by date.PNT operating margin by date.
N/AN/A55.38%-589.06%-307.66%-6.82%-58.37%14.87%31.60%30.53%38.23%
EPS
YoY % growth
PNT eps by date.PNT eps by date.
N/AN/AN/A
-52.78%		-0.89
9.21%		-1.04
-15.99%		0.56
153.87%		-0.69
-223.67%		0.80
215.25%		1.87
134.50%		1.55
-17.15%		1.92
24.51%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26
EPS
Q2Q % growth		-0.26
1.39%		-0.29
-81.80%		-0.30
-23.72%		-0.22
4.27%		-0.11
59.78%		-0.37
-28.47%		-0.37
-25.85%		-0.37
-69.72%		2.08
2,080.77%		-0.35
5.41%		-0.33
10.81%		-0.31
16.22%
Revenue
Q2Q % growth		2.289M
-98.99%		1.136M
-88.04%		1.136M
-76.82%		13.13M
368.93%		37.37M
1,532.59%		295.93M
25,950.18%		3.578M
214.96%		3.578M
-72.75%		284.08M
660.18%		2.562M
-99.13%		5.486M
53.33%		10.67M
198.21%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-33.46M
-117.48%		-33.498M
-48.88%		-34.447M
-9.35%		-22.077M
25.41%		1.214M
103.63%		-33.154M
1.03%		-33.154M
3.75%		-34.164M
-54.75%		-34.164M
-2,914.19%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PNT Yearly Revenue VS EstimatesPNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
PNT Yearly EPS VS EstimatesPNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
36.93%
EPS Next 5 Year
22.94%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
112.36%
Revenue Next 5 Year
72.58%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
38.92%
EBIT Next 5 Year
-10.32%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

POINT BIOPHARMA GLOBAL INC / PNT Forecast FAQ

What is the average price target for POINT BIOPHARMA GLOBAL INC (PNT) stock?

15 analysts have analysed PNT and the average price target is 15.05 USD. This implies a price increase of 20.36% is expected in the next year compared to the current price of 12.5.

When does POINT BIOPHARMA GLOBAL INC (PNT) report earnings?

POINT BIOPHARMA GLOBAL INC (PNT) will report earnings on 2024-03-22, after the market close.

Can you provide the consensus estimates for POINT BIOPHARMA GLOBAL INC next earnings?

The consensus EPS estimate for the next earnings of POINT BIOPHARMA GLOBAL INC (PNT) is -0.26 USD and the consensus revenue estimate is 2.29M USD.

What is the expected long term growth rate for PNT stock?

The expected long term growth rate for POINT BIOPHARMA GLOBAL INC (PNT) is 112.36%.